Microleakage Evaluation in Class V Cavities Restored with Five Different Resin Composites: In vitro Dye Leakage Study

Restorative materials and techniques have improved the clinical success of a variety of restorative procedures. Despite these new improvements, microleakage remains one of the leading causes of restoration failure and may lead to postoperative sensitivity, enamel microcracks, marginal staining, discoloration, recurrent caries, and deformation of teeth. This study evaluated microleakages of five recent resin composites in class V cavities.

Standardized class V cavities were prepared on the labial surfaces of one hundred extracted intact and noncarious human permanent premolar teeth. The cavities were divided into five groups (n=20) according to the resin composite material. Groups: A1, A2, A3, A4 and A5 were restored with Omnichroma, Spectrum, Mosaic, Tetric N-Ceram and Harmonize, respectively. The teeth were stained with methylene blue and then sectioned, and the extent of dye penetration was examined under a stereomicroscope and scanning electron microscope (SEM) to evaluate microleakage. One-way ANOVA test was used to statistically analyze the data. Statistical Package for Social Sciences Computer Software (SPSS) version 15.0 was used.

Dye penetration was observed at the tooth-restoration interface in all the studied samples, with varying degrees of penetration. At the cervical margins of the cavities, no statistically significant difference in the microleakage scores was observed (P=0.16). At the cavity floor, no statistically significant difference in microleakage scores was observed (P=0.74). Omnichroma resin composite had the highest microleakage results.

Nanohybrid resin composites showed less microleakage than other resin composites. Among all the groups, Omnichroma showed the highest microleakage at the cavity floor and at the cervical areas.

In light of our findings, nanohybrid resin composites appear to be capable of reducing microleakage, and the results reported herein must be verified by additional clinical trials.